BioSpace News Archive

Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today reported its financial results for the quarter and full-year ended December 31, 2023, and provided a corporate update.

Kane Biotech Inc. Dr. Robert Huizinga was elected as a director of the Company.

Centessa Pharmaceuticals plc today announced that members of its management team will participate in TD Cowen’s 44th Annual Health Care Conference in Boston, MA.

Autonomix Medical, Inc. announced it has completed selection of Principal Investigators for its proof-of-concept human clinical study evaluating the use of transvascular RF ablation for the treatment of pancreatic cancer pain.

Elanco Animal Health Incorporated (NYSE: ELAN) today announced that the Company will participate in the following investor conferences.

Artiva Biotherapeutics, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Artiva’s lead program AlloNK®.

Twist Bioscience Corporation today announced that its executives will participate in fireside chats at the following upcoming investor conferences.

Imugene Limited, a clinical stage immuno-oncology company, highlighted recent progress across the company’s immuno-oncology portfolio and provided an update on anticipated upcoming milestones.

The company Swiss Advanced Vision has announced the launch of New Features for its Toric Calculator improving the overall calculation experience.

AtomVie Global Radiopharma Inc. (AtomVie), a leading radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced strategic collaborations